Loading
Latest filing published 27 Jan 2016 for LISATA THERAPEUTICS, INC.. Read the official filing
No signal scores available.
Robert A. Preti is a declared insider of Lisata Therapeutics, Inc., with filings sourced from SEC (Form 4). In total, 2 filings cover trades dated 25 January 2016.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 27 January 2016, reports a share grant in Lisata Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations